Brief: Aptose Announces Executive Management Changes
07/04/2022 12:12
April 7 (Reuters) - Aptose Biosciences Inc APS.TO :
* APTOSE ANNOUNCES EXECUTIVE MANAGEMENT CHANGES
* ANNOUNCES RESIGNATION OF CFO/CBO JOTIN MARANGO
* JANET CLENNETT WILL ASSUME FINANCIAL RESPONSIBILITIES
UNTIL A
PERMANENT CFO IS ANNOUNCED
* CO AND MARANGO PLAN TO ENTER INTO AN ADVISORY AGREEMENT TO
ENSURE A SMOOTH TRANSITION FROM HIS CFO DUTIES
Source text for Eikon: ID:nGNX3JjdtM
Further company coverage: APS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aptose Biosciences
See all newsBrief: Aptose Biosciences Says Closing Of Arrangement With Hanmi Pharmaceutical Further Delayed
Brief: Aptose Reports First Quarter 2026 Results
Brief: Leading Independent Proxy Advisory Firm Glass Lewis Endorses Aptose Plan Of Arrangement
Brief: Leading Independent Proxy Advisory Firm Iss Recommends Aptose Biosciences Shareholders Vote “For” Proposed Plan Of Arrangement With Hanmi Pharmaceutical
Brief: Aptose Biosciences Announces Amendment To Arrangement Agreement And Details Of Shareholders Meeting